Skip to main content
Top
Published in: International Journal of Clinical Oncology 5/2014

01-10-2014 | Original Article

Prognostic predictors and spread patterns in adult ovarian granulosa cell tumors: a multicenter long-term follow-up study of 108 patients

Authors: Ibrahim Egemen Ertas, Kemal Gungorduk, Salih Taskin, Levent Akman, Aykut Ozdemir, Rifat Goklu, Mustafa Cosan Terek, Aydin Ozsaran, Yilmaz Dikmen, Yusuf Yildirim, Firat Ortac

Published in: International Journal of Clinical Oncology | Issue 5/2014

Login to get access

Abstract

Purpose

To identify prognostic predictors and spread patterns in adult ovarian granulosa cell tumors (OGCTs).

Methods

Available retrospective data of 108 OGCT patients managed at three centers between January 1, 1991 and December 31, 2010 were abstracted and analyzed.

Results

Stage distributions at diagnosis for stage I, II and III OGCT were 84.3, 5.4, and 9.3 %, respectively. Optimal cytoreduction with no macroscopically visible disease was achieved in 99/108 (91.6 %) patients. The median disease-free interval to first recurrence was 61 months. The overall 5- and 10-year survival rates were 93.3 and 90.9 %, respectively. Disease recurred in 18 (16.6 %) patients, and 8 (7.4 %) patients died of their disease. The first recurrence sites included the pelvic peritoneum (n = 10), liver/liver-capsule (n = 5), rectosigmoid colon (n = 4), retroperitoneal lymph nodes (n = 3), omentum (n = 3), small bowel mesenterium (n = 2), and vaginal cuff (n = 2). Multiple-site recurrence was observed in 9/18 (50 %) patients. Secondary cytoreduction requiring extensive surgery was performed in 14 patients with an optimality rate of 71.4 %. The remaining four patients received only chemotherapy. Multivisceral approaches, including pelvic peritonectomy (n = 9; 64.2 %), rectosigmoid resection (n = 3; 21.4 %), and segmental liver capsule resection (n = 2; 14.2 %) were performed more frequently during the secondary surgery. Definitive retroperitoneal lymph node metastasis rates at the initial and recurrent settings were 5.1 % (3/58) and 21.4 % (3/14), respectively. Both stage and residual tumor status were significantly associated with recurrence in univariate and multivariate analyses.

Conclusions

Stage and residual tumor status are predictors of recurrence. Pelvic peritoneal, nodal and hepatic involvement, and multiple-site spread patterns requiring extensive cytoreductive surgery are likely associated with recurrence of OGCTs.
Literature
1.
2.
go back to reference Pectasides D, Pectasides E, Psyrri A (2008) Granulosa cell tumor of the ovary. Cancer Treat Rev 34:1–12PubMedCrossRef Pectasides D, Pectasides E, Psyrri A (2008) Granulosa cell tumor of the ovary. Cancer Treat Rev 34:1–12PubMedCrossRef
3.
go back to reference Zhang M, Cheung MK, Shin JY et al (2007) Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—an analysis of 376 women. Gynecol Oncol 104:396–400PubMedCrossRef Zhang M, Cheung MK, Shin JY et al (2007) Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—an analysis of 376 women. Gynecol Oncol 104:396–400PubMedCrossRef
4.
go back to reference Lee YK, Park NH, Kim JW et al (2008) Characteristics of recurrence in adult-type granulosa cell tumor. Int J Gynecol Cancer 18:642–647PubMedCrossRef Lee YK, Park NH, Kim JW et al (2008) Characteristics of recurrence in adult-type granulosa cell tumor. Int J Gynecol Cancer 18:642–647PubMedCrossRef
5.
go back to reference Miller BE, Barron BA, Wan JY et al (1997) Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 79:1951–1955PubMedCrossRef Miller BE, Barron BA, Wan JY et al (1997) Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 79:1951–1955PubMedCrossRef
6.
go back to reference Chan JK, Zhang M, Kaleb V et al (2005) Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—a multivariate analysis. Gynecol Oncol 96:204–209PubMedCrossRef Chan JK, Zhang M, Kaleb V et al (2005) Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—a multivariate analysis. Gynecol Oncol 96:204–209PubMedCrossRef
7.
go back to reference Ayhan A, Salman MC, Velipasaoglu M et al (2009) Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. J Gynecol Oncol 20:158–163PubMedCrossRefPubMedCentral Ayhan A, Salman MC, Velipasaoglu M et al (2009) Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. J Gynecol Oncol 20:158–163PubMedCrossRefPubMedCentral
8.
go back to reference Mangili G, Ottolina J, Gadducci A et al (2013) Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer 109:29–34PubMedCrossRefPubMedCentral Mangili G, Ottolina J, Gadducci A et al (2013) Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer 109:29–34PubMedCrossRefPubMedCentral
9.
go back to reference Lee IH, Choi CH, Hong DG et al (2011) Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol 22:188–195PubMedCrossRefPubMedCentral Lee IH, Choi CH, Hong DG et al (2011) Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol 22:188–195PubMedCrossRefPubMedCentral
10.
go back to reference Park JY, Jin KL, Kim DY et al (2012) Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol 125:80–86PubMedCrossRef Park JY, Jin KL, Kim DY et al (2012) Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol 125:80–86PubMedCrossRef
11.
go back to reference Evans AT 3rd, Gaffey TA, Malkasian GD Jr et al (1980) Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 55:231–238PubMed Evans AT 3rd, Gaffey TA, Malkasian GD Jr et al (1980) Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 55:231–238PubMed
12.
go back to reference Stenwig JT, Hazekamp JT, Beecham JB (1979) Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 7:136–152PubMedCrossRef Stenwig JT, Hazekamp JT, Beecham JB (1979) Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 7:136–152PubMedCrossRef
13.
go back to reference Ohel G, Kaneti H, Schenker JG (1983) Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol 15:278–286PubMedCrossRef Ohel G, Kaneti H, Schenker JG (1983) Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol 15:278–286PubMedCrossRef
14.
go back to reference Sun HD, Lin H, Jao MS et al (2012) A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol 124:244–249PubMedCrossRef Sun HD, Lin H, Jao MS et al (2012) A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol 124:244–249PubMedCrossRef
15.
go back to reference Bjorkholm E, Petterson F (1980) Granulosa-cell and theca-cell tumors. The clinical picture and long-term outcome for the Radiumhemmet series. Acta Obstet Gynecol Scand 59:361–365PubMedCrossRef Bjorkholm E, Petterson F (1980) Granulosa-cell and theca-cell tumors. The clinical picture and long-term outcome for the Radiumhemmet series. Acta Obstet Gynecol Scand 59:361–365PubMedCrossRef
16.
go back to reference Ayhan A, Tuncer ZS, Tuncer R (1994) Granulosa cell tumor of the ovary. A clinicopathological evaluation of 60 cases. Eur J Gynaecol Oncol 15:320–324PubMed Ayhan A, Tuncer ZS, Tuncer R (1994) Granulosa cell tumor of the ovary. A clinicopathological evaluation of 60 cases. Eur J Gynaecol Oncol 15:320–324PubMed
17.
go back to reference Al-Badawi IA, Brasher PM, Ghatage P et al (2002) Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 12:119–123PubMedCrossRef Al-Badawi IA, Brasher PM, Ghatage P et al (2002) Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 12:119–123PubMedCrossRef
18.
go back to reference Uygun K, Aydiner A, Saip P et al (2003) Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecol Oncol 88:400–403PubMedCrossRef Uygun K, Aydiner A, Saip P et al (2003) Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecol Oncol 88:400–403PubMedCrossRef
19.
go back to reference Homesley HD, Bundy BN, Hurteau JA et al (1999) Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a gynecologic oncology group study. Gynecol Oncol 72:131–137PubMedCrossRef Homesley HD, Bundy BN, Hurteau JA et al (1999) Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a gynecologic oncology group study. Gynecol Oncol 72:131–137PubMedCrossRef
20.
go back to reference Pautier P, Gutierrez-Bonnaire M, Rey A et al (2008) Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 18:446–452PubMedCrossRef Pautier P, Gutierrez-Bonnaire M, Rey A et al (2008) Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 18:446–452PubMedCrossRef
21.
go back to reference Fotopoulou C, Savvatis K, Braicu El et al (2010) Adult granulosa cell tumors of the ovary: tumor dissemination pattern at primary and recurrent situation, surgical outcome. Gynecol Oncol 119:285–290PubMedCrossRef Fotopoulou C, Savvatis K, Braicu El et al (2010) Adult granulosa cell tumors of the ovary: tumor dissemination pattern at primary and recurrent situation, surgical outcome. Gynecol Oncol 119:285–290PubMedCrossRef
22.
go back to reference Mangili G, Sigismondi C, Frigerio L et al (2013) Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study. Gynecol Oncol 130:38–42PubMedCrossRef Mangili G, Sigismondi C, Frigerio L et al (2013) Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study. Gynecol Oncol 130:38–42PubMedCrossRef
23.
go back to reference Brown J, Sood AK, Deavers MT et al (2009) Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted? Gynecol Oncol 113:86–90PubMedCrossRef Brown J, Sood AK, Deavers MT et al (2009) Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted? Gynecol Oncol 113:86–90PubMedCrossRef
24.
go back to reference Abu-Rustum NR, Restivo A, Ivy J et al (2006) Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Gynecol Oncol 103:31–34PubMedCrossRef Abu-Rustum NR, Restivo A, Ivy J et al (2006) Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Gynecol Oncol 103:31–34PubMedCrossRef
25.
go back to reference Iyibozkurt AC, Topuz S, Gungor F et al (2010) Factors affecting recurrence and disease-free survival in granulosa cell tumors of the ovary. Eur J Gynaecol Oncol 31:667–671PubMed Iyibozkurt AC, Topuz S, Gungor F et al (2010) Factors affecting recurrence and disease-free survival in granulosa cell tumors of the ovary. Eur J Gynaecol Oncol 31:667–671PubMed
26.
27.
go back to reference Chua TC, Iyer NG, Soo KC (2011) Prolonged survival following maximal cytoreductive effort for peritoneal metastases from recurrent granulosa cell tumor of the ovary. J Gynecol Oncol 22:214–217PubMedCrossRefPubMedCentral Chua TC, Iyer NG, Soo KC (2011) Prolonged survival following maximal cytoreductive effort for peritoneal metastases from recurrent granulosa cell tumor of the ovary. J Gynecol Oncol 22:214–217PubMedCrossRefPubMedCentral
Metadata
Title
Prognostic predictors and spread patterns in adult ovarian granulosa cell tumors: a multicenter long-term follow-up study of 108 patients
Authors
Ibrahim Egemen Ertas
Kemal Gungorduk
Salih Taskin
Levent Akman
Aykut Ozdemir
Rifat Goklu
Mustafa Cosan Terek
Aydin Ozsaran
Yilmaz Dikmen
Yusuf Yildirim
Firat Ortac
Publication date
01-10-2014
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 5/2014
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-013-0630-x

Other articles of this Issue 5/2014

International Journal of Clinical Oncology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine